FMD Vaccine Bank
What's the Background?
An outbreak of FMD would immediately close all export markets. The cumulative impact of an outbreak on the beef and pork sectors over a 10-year period would be more than $128 billion, according to Iowa State University economists. The annual jobs impact of such a reduction in industry revenue is more than 58,000 in direct employment and nearly 154,000 in total employment. Corn and soybean farmers would lose $44 billion and nearly $25 billion, respectively, making the impact on these four industries alone almost $200 billion. A robust FMD vaccine bank can minimize the impact on the U.S. economy and reduce government costs to address an outbreak. The United States currently does not have access to enough FMD vaccine to handle more than a very small, localized outbreak…For more click here.
Why Does It Matter to Our Producers?
Foot and Mouth Disease (FMD) is an enormous risk to the U.S. livestock industry. An outbreak of the foreign animal disease would cripple the entire agricultural sector and have long-lasting ramifications for the economic viability of U.S. livestock production. It is essential that USDA APHIS have a robust and timely response capability in the form of a rapidly deployable FMD vaccine bank, sufficient laboratory capacity for disease surveillance and adequate response capability at the state level.
What is NPPC's position?
NPPC is requesting, through the next Farm Bill, that the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) develop an adequate vaccine bank to address an outbreak in the United States of Foot and Mouth Disease (FMD). APHIS should: contract for a manufacturer-managed FMD vaccine bank that would provide vaccine antigen concentrate to protect against all FMD strains currently circulating in the world; contract for manufacturing capacity that would produce in the shortest amount of time, including surge periods, enough vaccine to address the needs in the early stages of an outbreak and the millions of vaccine doses needed in the event of a medium- or large-scale outbreak; and develop an estimate of the cost for improvements to the vaccine bank…For more click here.